International Journal of Endocrinology / 2016 / Article / Tab 1

Research Article

Cardiometabolic Risk in Hyperlipidemic Men and Women

Table 1

Characteristics of the study sample, divided by sex.

(female/male)FemaleMale value

Age [years]35/640.001
BMI [kg/m2]34/610.998
Body weight34/61<0.001
Waist [cm]31/580.011
RRS [mmHg]24/450.089
RRD [mmHg]24/450.162
TC [mg/dL]35/640.290
LDL-C [mg/dL]34/600.174
LDL-C < 100 mg/dL34/609 (26.5%)17 (28.3%)0.911
HDL-C [mg/dL]33/60<0.001
NHDL-C [mg/dL]33/600.947
ln(TG) [mg/dL]35/640.008
ln(Lip.a) [units]30/570.031
IMT-left [mm]31/580.584
IMT-right [mm]30/560.824
IMT av [mm]30/560.711
Glucose [mg/dL]34/610.720
ln(insulin+1) [μU/mL]32/600.131
C-peptide [ng/mL]28/500.546
HbA1c [%]35/620.054
ln(proBNP) [units]30/55<0.001
ln(hsCRP+1) [units]30/620.161
ln(GOT) [mg/dL]34/640.263
ln(GPT) [mg/dL]34/640.021
ln(GGT) [mg/dL]34/640.003
Prediabetes34/6219 (55.9)29 (46.8)0.522
Ezetimibe33/553 (9.1)6 (10.9)1.000
Nicotinic acid33/541 (3.0)4 (7.4)0.646
Fibrates33/545 (15.2)22 (40.7)0.017
Statins33/5416 (48.5)38 (70.4)0.068
CVD33/602 (6.1)10 (16.7)0.202
Mean steps 7 days31/470.045
Metabolic syndrome21/447 (33.3)16 (36.4)1.000
Mean treatment duration of the last taken dyslipidemic medication (days)33/620.721

-test, Chi-square test.
Data are presented as number of observations () and means ± standard deviation. BMI (body mass index), waist (waist circumference), RRS (systolic blood pressure), RRD (diastolic blood pressure), TC (total cholesterol), LDL-C (low density lipoprotein cholesterol), HDL-C (high density lipoprotein cholesterol), NHDL-C (non-high density lipoprotein cholesterol), TG (triglycerides), TG/HDL (triglyceride/HDL-cholesterol ratio), Lip.a (lipoprotein (a)), IMT (carotid intima media thickness), HbA1c (glycated hemoglobin A1c), QUICKI (quantitative insulin sensitivity check index), proBNP (pro B-type natriuretic peptide), hsCRP (high sensitive C-reactive protein), GOT (glutamate-oxaloacetate transaminase), GPT (glutamate-pyruvate transaminase), GGT (gamma-glutamyl transferase), and CVD (cardiovascular disease).